EGFR and non-small cell lung carcinoma: A retrospective survey of records from patients with NSCLC tested for EGFR mutations during 2011 in 11 Asian Pacific countries found that only 31.8% of patients were tested.14 A Swedish study reviewing data from 2010 to 2012 found only 49% of patients with advanced-stage NSCLC with nonsquamous histology were referred for EGFR analysis, despite national guidelines recommending EGFR analysis.15 Because EGFR testing has become more prevalent, we sought to poll physicians to assess the current landscape.